241 related articles for article (PubMed ID: 22198379)
1. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Colak G; Johnson GV
Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
[TBL] [Abstract][Full Text] [Related]
2. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
[TBL] [Abstract][Full Text] [Related]
4. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 protects against ischemic stroke.
Filiano AJ; Tucholski J; Dolan PJ; Colak G; Johnson GV
Neurobiol Dis; 2010 Sep; 39(3):334-43. PubMed ID: 20451610
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
Quinn BR; Yunes-Medina L; Johnson GVW
J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
10. Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.
Sobrado M; Ramirez BG; Neria F; Lizasoain I; Arbones ML; Minami T; Redondo JM; Moro MA; Cano E
J Neuroinflammation; 2012 Mar; 9():48. PubMed ID: 22397398
[TBL] [Abstract][Full Text] [Related]
11. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.
Wang Z; Perez M; Lee ES; Kojima S; Griffin M
Cell Death Dis; 2017 Sep; 8(9):e3032. PubMed ID: 28880274
[TBL] [Abstract][Full Text] [Related]
12. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.
Mastroberardino PG; Iannicola C; Nardacci R; Bernassola F; De Laurenzi V; Melino G; Moreno S; Pavone F; Oliverio S; Fesus L; Piacentini M
Cell Death Differ; 2002 Sep; 9(9):873-80. PubMed ID: 12181738
[TBL] [Abstract][Full Text] [Related]
13. Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.
Yunes-Medina L; Paciorkowski A; Nuzbrokh Y; Johnson GVW
Mol Cell Neurosci; 2018 Jan; 86():72-80. PubMed ID: 29197584
[TBL] [Abstract][Full Text] [Related]
14. Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.
Pitolli C; Pietroni V; Marekov L; Terrinoni A; Yamanishi K; Mazzanti C; Melino G; Candi E
Amino Acids; 2017 Mar; 49(3):635-642. PubMed ID: 27864691
[TBL] [Abstract][Full Text] [Related]
15. Essential role of interleukin-6 in post-stroke angiogenesis.
Gertz K; Kronenberg G; Kälin RE; Baldinger T; Werner C; Balkaya M; Eom GD; Hellmann-Regen J; Kröber J; Miller KR; Lindauer U; Laufs U; Dirnagl U; Heppner FL; Endres M
Brain; 2012 Jun; 135(Pt 6):1964-80. PubMed ID: 22492561
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.
Yunes-Medina L; Feola J; Johnson GVW
Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946
[TBL] [Abstract][Full Text] [Related]
17. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific responses to loss of transglutaminase 2.
Deasey S; Shanmugasundaram S; Nurminskaya M
Amino Acids; 2013 Jan; 44(1):179-87. PubMed ID: 22194042
[TBL] [Abstract][Full Text] [Related]
20. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
Gundemir S; Johnson GV
PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
